We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mitral Valve Repair Via Catheter Offers Better Outcomes Than Pharmacological Treatment in Heart Failure Patients

By HospiMedica International staff writers
Posted on 13 Sep 2024

Approximately one-third of patients with heart failure experience a problem where the heart's mitral valve does not close properly, a condition known as mitral regurgitation. More...

As a result, individuals with this condition feel weak, fatigued, or have difficulty breathing and performing daily activities such as walking, climbing stairs, or carrying groceries. A new study has now demonstrated the benefits of placing a clip on the valve instead of the usual medical treatment.

The study involving researchers at Trias Hospital (Barcelona, Spain) showed that this significant benefit also applies to patients with moderate mitral regurgitation. This finding, published in the New England Journal of Medicine, enables faster treatment and improves the patient's clinical condition before it becomes too late. The catheter-based treatment involves placing a clip on the mitral valve without the need for surgery, through a minimally invasive procedure that only requires a 2-3 day hospital stay, enabling patients to quickly return to their normal lives. The study involved 505 patients from 30 centers in nine countries, divided into two groups: one group received mitral valve repair along with the recommended medical treatment, while the other group received only the usual medical treatment.

After 24 months, the group that received the valve repair showed a significant reduction in the rate of recurrent hospitalizations for heart failure or cardiovascular death compared to the group that only received medical treatment. Additionally, patients who underwent valve repair experienced a notable improvement in their quality of life after 12 months, as measured by the Kansas City Cardiomyopathy Questionnaire. This international study could represent a turning point in the treatment of many patients with mitral valve insufficiency.

"We now have new evidence showing that a minimally invasive procedure is beneficial even in less severe patients, and this should revolutionize clinical guidelines," said Professor Antoni Bayés-Genís from Germans Trias Hospital, adding that the goal "should always be to improve these patients' quality of life and prevent them from needing hospitalization, and this study proves that."

Related Links:
Germans Trias Hospital


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.